Send to

Choose Destination
Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H123-H133. doi: 10.1152/ajpheart.00075.2018. Epub 2018 Oct 19.

Genetic deletion of the alamandine receptor MRGD leads to dilated cardiomyopathy in mice.

Author information

Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil.
National Institute in Science and Technology NanoBioFar , Belo Horizonte, Minas Gerais , Brazil.
Department of Biochemistry and Immunology, Federal University of Minas Gerais , Belo Horizonte, Minas Gerais , Brazil.
Max-Delbrück Center for Molecular Medicine, Berlin-Buch, Germany.
German Center for Cardiovascular Research, Berlin Partner Site, Berlin , Germany.
Charite-University Medicine, Berlin , Germany.
Berlin Institute of Health , Berlin , Germany.


We have recently described a new peptide of the renin-angiotensin system, alamandine, a derivative of angiotensin-(1-7). Mas-related G protein-coupled receptor member D (MrgD) was identified as its receptor. Although similar cardioprotective effects of alamandine to those of angiotensin-(1-7) have been described, the significance of this peptide in heart function is still elusive. We aimed to evaluate the functional role of the alamandine receptor MrgD in the heart using MrgD-deficient mice. MrgD was localized in cardiomyocytes by immunofluorescence using confocal microscopy. High-resolution echocardiography was performed in wild-type and MrgD-deficient mice (2 and 12 wk old) under isoflurane anesthesia. Standard B-mode images were obtained in the right and left parasternal long and short axes for morphological and functional assessment and evaluation of cardiac deformation. Additional heart function evaluation was performed using Langendorff isolated heart preparations and inotropic measurements of isolated cardiomyocytes. Immunofluorescence indicated that the MrgD receptor is expressed in cardiomyocytes, mainly in the membrane and perinuclear and nuclear regions. Echocardiography showed left ventricular remodeling and severe dysfunction in MrgD-deficient mice. Strikingly, MrgD-deficient mice presented a pronounced dilated cardiomyopathy with a marked decrease in systolic function. Echocardiographic changes were supported by the data obtained in isolated hearts and inotropic measurements in cardiomyocytes. Our data add new evidence for a major role for alamandine/MrgD in the heart. Furthermore, our results indicate that we have identified a new gene implicated in dilated cardiomyopathy, unveiling a new target for translational approaches aimed to treat heart diseases. NEW & NOTEWORTHY The renin-angiotensin system is a key target for cardiovascular therapy. We have recently identified a new vasodepressor/cardioprotective angiotensin, alamandine. Here, we unmasked a key role for its receptor, Mas-related G protein-coupled receptor member D (MrgD), in heart function. The severe dilated cardiomyopathy observed in MrgD-deficient mice warrants clinical and preclinical studies to unveil its potential use in cardiovascular therapy.


Mas-related G protein-coupled receptor member D; alamandine; dilated cardiomyopathy

LinkOut - more resources

Full Text Sources

Molecular Biology Databases

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center